<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221016056192N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-27</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>A comparison of one burr hole vs two burr holes surgery in recurrence of chronic subdural hematoma</public_title>
      <acronym></acronym>
      <scientific_title>A comparison of one burr hole vs two burr holes surgery in recurrence of chronic subdural hematoma</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66394</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random lists of patient allocation will be based on random blocks of 4, 6 and 8. The allocation would be concealed by the randomizer and the person in charge of randomization wouldn't be aware of the treatment they groups would receive. We will generate these random blocks using www.sealedenvelope.com. (Sealed Envelope Ltd. 2022. Create a blocked randomisation list. [Online] Available from: https://www.sealedenvelope.com/simple-randomiser/v1/lists), Blinding description: In this study, we want to investigate two different surgical procedures and since the patients and their relatives will receive a complete description of possible interventions in this study, blinding the patients wouldn't be possible. The patients will have the same number of scalp incisions and scars as the number of burr holes used and that's why they can't be blinded. This is also true for outcome assessors as they can also become aware of allocated groups.
Those who'll be performing the procedure would become aware of it and they can't be blinded too.
So, in this study only those who analyze and manage the data can be and will be blinded to the allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>chronic subdural hematoma in brain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  patients who will undergo one bur hole method surgery. patients will go under general anesthesia in both groups. in the supine position, superior to the superior temporal line, an incision will make. after preparing the skull bone, one bur hole will prepare by the perforator. after coagulation and opening of the dura and exiting of SDH fluid, we will irrigate into the hole with warm 37-degree sterile normal saline serum with a syringe until the exiting fluid is clear. a subperiosteal drain will be fixed. the small incision will be sutured by a 2-0 nylon thread.  the drain will be equal to the level of the patient's head. Intervention 2: Control group: patients who will undergone two bur hole method surgery. all the steps will be the same as intervention group but instead of one incision, two incision will made superior to superior temporal line and one bur hole in each will be prepared. irrigation will be done from both holes. in the end, similar to other group, one drain will be fix in anterior incision.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data will contain age, sex, surgery method, time of recurs, blood loss, primary symptoms and brain CT features. 
whole data will be shared after identified process was done.

When:
data files will be available one month after publication.

To whom:
Data will be available for people working in academic institutes .

Conditions:
data will be shared for whom doing studies about outcomes of cSDH surgery to improve or describe methods of surgery.

Where to obtain:
all people working in academic institutes can contact E-mail address below : faramarzroohollahi@yahoo.com

How to obtain:
after receiving E-mail for accessing file of data, we will respond in less than 48 hours.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Faramarz Roohollahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shariati hospital, Kargar Shomali</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411713135</zip>
        <telephone>+98 21 8800 6684</telephone>
        <email>faramarzroohollahi@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Faramarz Roohollahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shariati hospital, Kargar Shomali</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411713135</zip>
        <telephone>00892188006684</telephone>
        <email>faramarzroohollahi@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>male or female patients more than 18 years old
a minimum of 5 mm shift in brain CT scan
obvious pressure effect on cortex underlying hematoma
clinical symptoms justifiable to hematoma</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>pregnancy period
breastfeeding period
Sepsis
active psychological disorders
second surgery in first 48 hours because of technical issues
patients who will not attend for follow up
history of CSF diversion surgery
empyema</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I62.03</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Nontraumatic chronic subdural hemorrhage</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  patients who will undergo one bur hole method surgery. patients will go under general anesthesia in both groups. in the supine position, superior to the superior temporal line, an incision will make. after preparing the skull bone, one bur hole will prepare by the perforator. after coagulation and opening of the dura and exiting of SDH fluid, we will irrigate into the hole with warm 37-degree sterile normal saline serum with a syringe until the exiting fluid is clear. a subperiosteal drain will be fixed. the small incision will be sutured by a 2-0 nylon thread.  the drain will be equal to the level of the patient's head.</i_keyword>
      <i_keyword>Control group: patients who will undergone two bur hole method surgery. all the steps will be the same as intervention group but instead of one incision, two incision will made superior to superior temporal line and one bur hole in each will be prepared. irrigation will be done from both holes. in the end, similar to other group, one drain will be fix in anterior incision.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Recurrence outcome explained as incidence new deficits or exacerbation of clinical condition of patient any time after 48 hours to 6 months of surgery which will confirm with new brain CT scan  revealing new hematoma. Timepoint: 1 month and 6 month since surgery. Method of measurement: patients must attend to clinic for check up after 1 month and 6 month of surgery.. if there was neurological deficit CT will be done and recurrence will be assesd.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-04</approval_date>
        <contact_name>shariati hospital ethics committe,tehran university of medical scince</contact_name>
        <contact_address>kargar shomali sreet Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
